Effect of Stellate Ganglion Block on ME/CFS
Public ClinicalTrials.gov record NCT05664711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Stellate Ganglion Block on ME/CFS Symptoms and Metabolites
Study identification
- NCT ID
- NCT05664711
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Neuroversion, Inc.
- Other
- Enrollment
- 10 participants
Conditions and interventions
Conditions
- Encephalomyelitis, Myalgic
- Chronic Fatigue Syndrome
- Chronic Fatigue Disorder
- Chronic Fatigue and Immune Dysfunction Syndrome
- Myalgic Encephalomyelitis
- Postviral Fatigue Syndrome
- Systemic Exertion Intolerance Disease
- Infectious Mononucleosis-Like Syndrome, Chronic
- Chronic Fatigue-Fibromyalgia Syndrome
Interventions
- Bupivacaine Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2023
- Primary completion
- Dec 20, 2023
- Completion
- Jan 14, 2024
- Last update posted
- Dec 5, 2024
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neuroversion | Anchorage | Alaska | 99508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05664711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05664711 live on ClinicalTrials.gov.